This collaboration aims to significantly enhance data processing speeds to handle the increased data volume from Proteus.
Concurrently, Quantum-Si and SkyWaterTechnology will jointly expand their relationship to support the development of Proteus.
The expanded collaboration will develop the consumable for Proteus, enabling simultaneous large-factor protein sequencing.
Quantum-Si and SkyWater began partnering in 2021 on the first-generation Platinum platform and announced the transition to support production in the second quarter of 2024.
SkyWater will continue to supply the consumables for the Platinum Pro product as the two companies expand their engagement to support the commercialization of Proteus.
Quantum-Si also partnered with Planet Innovation to develop and manufacture Proteus.
Currently, Planet Innovation is the contract manufacturer for Quantum-Si’s Platinum Pro instrument, which will debut in the first half of 2025.
On Wednesday, Quantum-Si announced a distribution agreement with Avantor Inc (NASDAQ:AVTR).
Through this collaboration, Avantor will distribute Quantum-Si’s Next-Generation Protein Sequencing (NGPS) portfolio to researchers across all market segments in the U.S. and Canada.
The distribution agreement enables Avantor to offer Quantum-Si’s protein sequencing technology to a broad range of laboratories focused on proteomics.
Quantum-Si’s platform leverages single-molecule sequencing technology, with applications across protein and biomarker identification, antibody characterization, protein barcoding, and post-translational modification analysis to deliver insights into protein structure and function.
Price Action: QSI stock is up 119% at $1.39 during the premarket session at last check Wednesday.
Read Next:
Photo: Gorodenkoff/Shutterstock.com
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
